CHSCM · Chs Inc
Price & Indicators
Latest filings
CHS Inc. reported that Russell Kehl resigned from its Board of Directors effective December 2, 2026, creating a one-year Region 6 vacancy. Candidates will be nominated at the CHS 2026 Annual Meeting of Members to fill the position.
Read the 8-KQuarterly results
* Q4 derived as the full year minus Q1 to Q3.
Technicals
trend & momentum for long-term holders illustrative — not investment adviceIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Farm Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CHSCM
this stock
Chs Inc
|
— | -7.9% | -9.7% | — | — |
|
ADM
Archer-Daniels-Midland Co
|
$37.69B | +36.0% | -6.2% | 21.4 | 2.5% |
|
BG
Bunge Global SA
|
$19.67B | +13.8% | +32.4% | 19.7 | 4.0% |
|
TSN
Tyson Foods, Inc.
|
$19.57B | -4.9% | +2.1% | 34.4 | 2.8% |
|
CALM
Cal-Maine Foods Inc
|
$2.91B | -21.6% | -31.7% | — | 13.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Oct 5, 2026
- This year
- 13
CHS Inc. reported that Russell Kehl resigned from its Board of Directors effective December 2, 2026, creating a one-year Region 6 vacancy. Candidates will be nominated at the CHS 2026 Annual Meeting of Members to fill the position.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CHSCM | -0.5% | -4.3% | -9.3% | -5.3% | -7.9% |
| SPY | +0.1% | +0.7% | +4.9% | +0.9% | +12.9% |
| vs SPY | -0.6% | -5.0% | -14.2% | -6.2% | -20.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.